Welcome : Guest

DNA PROBES-BASED DIAGNOSTICS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 46 companies including many key and niche players such as -

Abbott Molecular
Affymetrix, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMérieux

Click here to request a full list of companies covered in the report...

Code: MCP-3405
Price: $4500
Companies: 46
Pages: 237
Date: July 2016
Market Data Tables: 95
  Status: * New Report



TABLE OF CONTENTS


  DNA PROBES-BASED DIAGNOSTICS (Complete Report) Pages : 237   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   What are DNA-Probes?.....II-1
DNA-based Diagnostics – A Prelude.....II-1
1$100
   DNA Tests: Finding Use in Numerous Applications.....II-2
DNA Probes: Robust Growth Ahead.....II-2
1$100
   Developed Markets: Traditional Revenue Contributors.....II-3
The United States: Unraveling the Country’s Edge in DNA-based Diagnostics.....II-3
1$100
   Infectious Diseases Tests Dominate the DNA-based Diagnostics Market.....II-4
Developing Countries Excel in Growth Prospects.....II-4
1$100
   Decoding the Genetic Puzzle.....II-51$100
   Advantages of DNA-Probe Tests.....II-6
Growth Drivers in a Nutshell.....II-6
Growth Inhibitors in a Nutshell.....II-6
Genetic Profiling of Pathogens: A Road Less Traveled.....II-6
1$100
   Roche’s Entry into the Hall of Molecular Fame.....II-7
DNA Technology: An Evolutionary Scan.....II-7
1$100
   Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005.....II-81$100
   Market Opportunities.....II-91$100
   World’s Aging Population Drives the Popularity of DNA-Probe Tests.....II-10
Global Aging Population Statistics – Opportunity Indicators.....II-10
Table 1: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart).....II-10
1$350
   Table 2: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-111$350
   Table 3: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-12
Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based
  Diagnostics.....II-12
1$350
   Table 4: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-131$350
   Table 5: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart).....II-14

Table 6: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart).....II-14
1$350
   Table 7: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart).....II-15
AIDS: A Global Epidemic.....II-15
Facts & Figures.....II-15
1$350
   Table 8: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart).....II-161$350
   Table 9: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart).....II-171$350
   Table 10: Worldwide AIDS related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart).....II-18
Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth.....II-18
1$350
   Table 11: Select Countries with Healthcare Spending as a Percentage of GDP (2014) (includes corresponding Graph/Chart).....II-19
Reimbursements: “Under the Umbrella”.....II-19
1$350
   Evolution of New & Virulent Infectious Agents.....II-20
Challenges in Widespread Deployment of DNA-based Diagnostics.....II-20
Improvements in Assay Capabilities.....II-20
Information Handling & Processing: The Soft Side of Diagnostics.....II-20
1$100
   Integration: The Ultimate Challenge.....II-21
DNA Probe Technology Gains Prominence in Diagnosing Vaginitis.....II-21
Gene Banks – A Ray of Hope for the Future.....II-21
1$100
   Diagnostic Gene Detection Products.....II-22
Molecular Diagnostics: A Powerful Disease Detection Tool.....II-22
1$100
   DNA Probes-Based Products.....II-23
Direct Detection of Target Sequence.....II-23
Nucleic Acid Amplification.....II-23
1$100
   Gene Detection Using DNA Chips.....II-24
Gene Detection by DNA Sequencing.....II-24
The Dynamics of Key Enabling Technologies.....II-24
Polymerase Chain Reaction (PCR).....II-24
In situ Hybridization.....II-24
1$100
   Chemiluminescence.....II-25
Gen-Probe Tigris.....II-25
DNA Chips.....II-25
Molecular Diagnostics – A Primer.....II-25
1$100
   Implications for Clinical Diagnostics.....II-26
Need of the Hour.....II-26
Impact of the Human Genome Project.....II-26
1$100
   “Tailored Patient Management”: An Epitomized Future of Molecular Diagnostics.....II-27
Outlook.....II-27
2$200
   Background.....II-29
Gene Probe Technology.....II-29
What is DNA?.....II-29
DNA Probes.....II-29
1$100
   Miniaturization: A Revolutionary Method in DNA Analysis.....II-30
Gene Chip Technology.....II-30
DNA Chips.....II-30
Chromosome Painting Probes.....II-30
Diagnostic Applications Based on DNA Probes: An Overview.....II-30
Infectious Diseases.....II-30
2$200
   Respiratory Tract Infections.....II-32
Diagnosis of Mycoplasma.....II-32
DNA Probes to Detect Legionella Pneumophila.....II-32
Detecting Tuberculosis through Rapid Diagnostic Tests.....II-32
How the Technique Works.....II-32
1$100
   Limitations.....II-33
Sexually Transmitted Diseases (STDs).....II-33
HIV.....II-33
HTLV-1 Testing.....II-33
Hepatitis Testing.....II-33
Chlamydia DNA Probes.....II-33
Detection of Intestinal Parasites.....II-33
Entamoeba Histolytica.....II-33
1$100
   Salmonella.....II-34
Malaria Testing.....II-34
Identity/Forensics.....II-34
DNA Profiling: A Key Forensic Tool.....II-34
DNA-Based Forensic Diagnostics.....II-34
1$100
   Tracing Human Origins.....II-35
Genetic Predisposition.....II-35
1$100
   Molecular HLA Testing.....II-36
Human Leukocyte Antigen (HLA) Typing.....II-36
Cancer Testing.....II-36
Cancer: A Deadly Disease Afflicting Millions.....II-36
Slow Detoxifiers: Potential Cancer Candidates.....II-36
1$100
   Improving Cancer Surgery through Diagnostic Tests.....II-37
Types of Cancer.....II-37
Chronic Lymphocytic Leukemia (CLL).....II-37
Breast Cancer.....II-37
PCR Screening Technology for Breast Cancer.....II-37
1$100
   Eye Cancers.....II-38
DNA Probes to Detect Retinoblastoma.....II-38
Others.....II-38
The Ames test.....II-38
Genetic Testing.....II-38
1$100
   Other Diagnostic Applications.....II-39
Cystic Fibrosis.....II-39
Duchenne’s Muscular Dystrophy.....II-39
Huntington’s Disease.....II-39
Diabetes.....II-39
1$100
   Detection of Multidrug Resistance.....II-40
Bacterial Resistance to Antibiotics.....II-40
1$100
   DLCS Unveils In-House DNA Fish Test for Melanoma.....II-41
Agilent Technologies Introduces New SureFISH Break-Apart Probes.....II-41
Beckman Coulter Life Sciences Rolls Out PerFix-Expose1 and PerFix-nc1.....II-41
1$100
   Thermo Fisher Scientific Acquires Affymetrix.....II-42
Illumina Partners with Memorial Sloan Kettering.....II-42
Cancer Genetics to Acquire BioServe Biotechnologies.....II-42
Co-Diagnostics to Acquire DNA Logix’ Technologies.....II-42
Leica Biosystems Takes Over Kreatech Diagnostics and Aotec.....II-42
1$100
   Abbott Molecular (USA).....II-43
Affymetrix, Inc. (USA).....II-43
Beckman Coulter, Inc. (USA).....II-43
1$100
   Becton, Dickinson and Company (USA).....II-441$100
   bioMérieux (France).....II-45
F. Hoffmann-La Roche Ltd. (Switzerland).....II-45
GE Healthcare Life Sciences (UK).....II-45
1$100
   Luminex Corporation (USA).....II-46
QIAGEN N.V. (Netherlands).....II-46
1$100
   Siemens Healthineers (Germany).....II-471$100
   Table 12: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-481$350
   Table 13: World Historic Review for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-491$350
   Table 14: World 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-501$350
   Table 15: World Recent Past, Current & Future Analysis for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-511$350
   Table 16: World Historic Review for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-521$350
   Table 17: World 14-Year Perspective for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-531$350
   Table 18: World Recent Past, Current & Future Analysis for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-541$350
   Table 19: World Historic Review for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-551$350
   Table 20: World 14-Year Perspective for DNA Probes-based Cancer Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-561$350
   Table 21: World Recent Past, Current & Future Analysis for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-571$350
   Table 22: World Historic Review for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-581$350
   Table 23: World 14-Year Perspective for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-591$350
   Table 24: World Recent Past, Current & Future Analysis for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-601$350
   Table 25: World Historic Review for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-611$350
   Table 26: World 14-Year Perspective for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-621$350
   Table 27: World Recent Past, Current & Future Analysis for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-631$350
   Table 28: World Historic Review for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-641$350
   Table 29: World 14-Year Perspective for DNA Probes-based Other Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-651$350
   A. Market Analysis.....III-1
United States: The Largest Market for DNA-Probes Diagnostics.....III-1
1$75
   Key Challenges Facing the Market.....III-2
Rise of DNA-Based Home Testing Kits Market.....III-2
Ageing Demographics: A Major Driving Factor.....III-2
1$75
   Table 30: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-3
Diabetes Pandemic in the US: An Opportunity for DNA Probes-based Diagnostics.....III-3
1$200
   Table 31: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-4

Table 32: US Diabetes Prevalence (in 000’s) for 2010-2017P (includes corresponding Graph/Chart).....III-4
1$200
   Table 33: Diabetes Prevalence in the US by Type: 2013 (includes corresponding Graph/Chart).....III-5

Table 34: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart).....III-5
Growing Cancer Incidence – An Opportunity Indicator for DNA Probes-Based
  Diagnostics.....III-5
1$200
   Table 35: New Cancer Cases in the US by Gender and Affected Site: 2014 (includes corresponding Graph/Chart).....III-61$200
   Table 36: Incidence of Cancer for All Body Sites by Gender & Age Group in the US (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; 65 years and Above (includes corresponding Graph/Chart).....III-71$200
   Table 37: The US Breast Cancer Incidence in Women by State (2013): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart).....III-8
Product Launches.....III-8
1$200
   Strategic Corporate Developments.....III-9
Focus on Select Key Players.....III-9
3$225
   B. Market Analytics.....III-12
Table 38: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-12
1$200
   Table 39: The US Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-131$200
   Table 40: The US 14-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-141$200
   A. Market Analysis.....III-15
Cancer Incidence in Canada: Opportunity Indicator.....III-15
Table 41: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart).....III-15
1$200
   Table 42: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart).....III-161$200
   Table 43: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart).....III-171$200
   Diabetes Statistics in Canada.....III-18
Table 44: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart).....III-18

Table 45: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-18
1$200
   B. Market Analytics.....III-19
Table 46: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-19
1$200
   Table 47: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-201$200
   Table 48: Canadian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-211$200
   A. Market Analysis.....III-22
Graying Population Spurs Growth.....III-22
Table 49: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-22
1$200
   B. Market Analytics.....III-23
Table 50: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-23
1$200
   Table 51: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-241$200
   Table 52: Japanese 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Ageing Population Drives Demand.....III-26
1$75
   Table 53: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....III-271$200
   Cancer Incidence in Europe: An Opportunity Indicator for DNA Probes-Based
  Diagnostics.....III-28
Table 54: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart).....III-28
1$200
   A Glance at Key Diabetes Statistics in Europe.....III-29
Table 55: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart).....III-29
1$200
   Table 56: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-301$200
   B. Market Analytics.....III-31
Table 57: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-31
1$200
   Table 58: European Historic Review for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-321$200
   Table 59: European 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-331$200
   Table 60: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-341$200
   Table 61: European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-351$200
   Table 62: European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-361$200
   A. Market Analysis.....III-37
bioMérieux – A Major French Player.....III-37
1$75
   B. Market Analytics.....III-38
Table 63: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-38
1$200
   Table 64: French Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-391$200
   Table 65: French 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Strategic Corporate Development.....III-41
Siemens Healthineers – A Key German Player.....III-41
1$75
   B. Market Analytics.....III-42
Table 66: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-42
1$200
   Table 67: German Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-431$200
   Table 68: German 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-441$200
   Market Analysis.....III-45
Table 69: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-45
1$200
   Table 70: Italian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-461$200
   Table 71: Italian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
GE Healthcare Life Sciences – A Leading UK Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 72: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-49
1$200
   Table 73: The UK Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-501$200
   Table 74: The UK 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-511$200
   Market Analysis.....III-52
Table 75: Spanish Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-52
1$200
   Table 76: Spanish Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   Table 77: Spanish 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 78: Russian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-55
1$200
   Table 79: Russian Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-561$200
   Table 80: Russian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-571$200
   A. Market Analysis.....III-58
Focus on Select Key Players.....III-58
2$150
   B. Market Analytics.....III-60
Table 81: Rest of European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-60
1$200
   Table 82: Rest of European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-611$200
   Table 83: Rest of European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Diabetes Statistics – An Overview.....III-63
1$75
   Table 84: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-641$200
   Table 85: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-651$200
   Table 86: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-661$200
   Table 87: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-67
Strategic Corporate Development.....III-67
1$200
   B. Market Analytics.....III-68
Table 88: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-68
1$200
   Table 89: Asia-Pacific Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-691$200
   Table 90: Asia-Pacific 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-701$200
   A. Market Analysis.....III-71
Diabetes in Latin America – A Glance at Key Statistics.....III-71
1$75
   Table 91: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-721$200
   Table 92: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-731$200
   B. Market Analytics.....III-74
Table 93: Rest of World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-74
1$200
   Table 94: Rest of World Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-751$200
   Table 95: Rest of World 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-761$200
  
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 57)

Region/Country Players

The United States 37 Canada 2 Japan 1 Europe 13 France 1 Germany 3 The United Kingdom 2 Italy 1 Spain 1 Rest of Europe 5 Asia-Pacific (Excluding Japan) 4
Click here to request a full table of contents and more details on this project.